Clinical Trial

Prevalence and Severity of Depression in Coronary Artery Disease Patients

Study acronym: PAD-CAD
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 18, 2025 (before its estimated April 20, 2025 completion). Its status may not reflect the trial's current state.
Summary
This observational study aims to estimate the prevalence and severity of depression among patients with coronary artery disease (CAD) in Baghdad, Iraq, using the self-administered PHQ-9 questionnaire. The study seeks to answer the following questions: What is the prevalence of depression among CAD patients? How is the severity of depression distributed within this group? Are specific demographic, clinical, or environmental factors associated with higher levels of depression? Participants will: Complete the PHQ-9 to assess the severity of depressive symptoms at a specific point in time. Provide demographic and clinical information, including age, gender, socioeconomic status, comorbidities, and CAD-related factors such as type of intervention and duration of illness, to explore potential correlations with depression.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2024-12-14; most recent amendment 2025-03-16.
Status change: Not Yet Recruiting → Recruiting 2025-02-24
Trial Details
NCT Number NCT06740396
Lead Sponsor Al-Nahrain University
Conditions Depression - Major Depressive Disorder
Enrollment 200 participants
Start Date 2025-02-20
Primary Completion 2025-04-20 (estimated)
Study Completion 2025-04-30 (estimated)
Updated on ClinicalTrials.gov 2025-03-18